Bangkok Pattaya Hospital, the first private hospital in ASEAN, in cooperation with Huawei and Chanwanich, introduces AI solutions in a bid to boost its fight against Covid-19
Apr 22, 2020
Bangkok Hospital Pattaya, an affiliate of BDMS, in cooperation with Huawei Technologies (Thailand) Co., Ltd., HY Medical from China, and Chanwanich Co., Ltd. (Chanwanich), jointly developed Artificial Intelligence (AI) technology to assist in the screening and diagnosis for traces in patients undergoing treatment for COVID-19, a technology that has successfully used in tackling the COVID-19 crisis in China, thereby establishing Bangkok Hospital Pattaya to be regarded as the first private hospital in the region that has adopted such technology which will be used to help support medical personnel in more accurate screening and diagnosis of the virus.
Pictured – Mr. Saravut Kongboonma (5th from left), executive representative from Chanwanich Co., Ltd., together with Mr. Ding Le (3rd from left), Director of Cloud Partners, Huawei Technologies (Thailand) Co., Ltd., delivers the identical AI-based technology that has been used to overcome the COVID-19 crisis in leading Chinese hospitals, to Bangkok Hospital Pattaya, with Dr. Kongkiat Kespechara (4th from left), CEO Group 3 of the BDMS Group, who was on hand to accept.
In the cooperation effort, Bangkok Hospital Pattaya, an affiliate of BDMS, will provide medical personnel support to help diagnose, conduct testing and receive the transfer of technical know-how and the various models of analysis together with experts from China. The technology is supported by Huawei and HY Medical, in transferring ideas and lessons for system installation guidelines through remote communication systems from China, with Chanwanich taking the lead in adapting for it to work efficiently in Thailand. Collaborative brainstorming and ideas were contributed from the hospital’s radiologists, as well as analysis of x-rays and CT scans together with support from the IT and 4 technical support teams, consultants and experts from China, to enable the system to work successfully.
Huawei’s AI solution on HUAWEI CLOUD diagnoses CT quantification results for the analysis of COVID-19 infection in patients’ lungs. Moreover, the AI solution also effectively identifies the phase of infection: early, advanced, and severe stages with the high accuracy rate of 96% for image analyzing per case within seconds. Currently, there are over 20 hospitals in China that adopt this artificial intelligence technology to encounter the COVID-19 situation. Recently, in Thailand, Huawei has provided the solution to Ramathibodi Hospital and Siriraj Hospital.
Dr. Kongkiat Kespechara, CEO Group 3 of the BDMS Group thanks the Huawei Technologies (Thailand) Co., Ltd. and Chanwanich Co., Ltd. teams.
Mr. Ding Le, Huawei Cloud Partner Alliance Director, Huawei Technologies (Thailand) Co., Ltd, stated that, “The AI solution is part of HUAWEI CLOUD which is a vital tool in assisting the COVID-19 diagnosis. Furthermore, HUAWEI CLOUD also empowers the capacity of the healthcare industry in other facets with its full potential, reliability and safety. With full portfolio of applications and services tailored to medical usage ranging from biomedical, chronic diseases, medical image storage, DNA base sequencing to Digital Hospital, we believe that this cooperation is the first important step of private sector in collectively enhancing Thailand’s medical standard to an intelligent digital era.”
Mr. Ding Le, Director of Cloud Partners, Huawei Technologies (Thailand) Co., Ltd.
Chanwanich Co., Ltd. sent a development and support team to help in the successful transfer of knowledge and technology to Thailand, and this team is also responsible for driving the interlinking of all operations to enable it to commence work immediately. The entire process took only 2 weeks, starting from initial discussions, setting up of the system, and finally the cutover to actual usage. Chanwanich is determined to develop health and public health systems in a bid to upgrade the medical capability for Thais, to evolve into a comprehensive “integrated health solution”.
Mr. Saravut Kongboonma, representative of Chanwanich development team, in a discussion with Dr. Kongkiat Kespechara, CEO Group 3 of BDMS Group.
Mr. Thanapol Kongboonma, CEO of Chanwanich Co., Ltd., expresses his appreciation to Huawei Technologies (Thailand) for coming onboard as a strategic partner for Thailand, enabling access to AI technology which is expected to change the public’s living habits after the COVID-19 crisis has subsided. He also wishes to provide encouragement to the team of doctors, nurses, and medical professionals in the BDMS group who has dedicated themselves in helping us get through the crisis. Finally, Chanwanich wishes to provide assistance and support for the transfer of technology and the creation of good health and public health systems, by being a trusted company known for its reliability and trustworthiness in its collaborative efforts to invent and innovate.
In this mission, we would like to be an integral part of helping Thailand overcome the COVID-19 crisis. Please convey our moral support for all of the medical personnel, nurses, as well as every other support teams who have contributed in taking care of the health of the Thai people.